Search - tctmd.com

Displaying 521 - 540 of 626

Sort: Relevancy | Date

News Daily News

Watchman Device for LAA Closure Provides Net Clinical Benefit vs. Warfarin in A-fib Patients

September 27, 2012

News Daily News

El Dispositivo Watchman para el Cierre del AAI Ofrece Beneficios Clínicos Netos comparado con la Warfarina en Pacientes con FA

September 27, 2012

Presentation

Optimal Anticoagulant/Antiplatelet Therapy in Challenging Subsets: A Post-ESC Late Breaking Trial Roundup

Presenter: 62744|Gregg Stone

September 18, 2012

Presentation VEINS 2012

Anticoagulants: What is New in VTE

Presenter: John R. Bartholomew

September 14, 2012

News Daily News

El Uso del Dabigatran va a Más tanto contra la FA como Fuera de Indicación

September 12, 2012

News Daily News

Dabigatran Usage up, Both for A-fib and Off-Label Indications

September 12, 2012

Presentation

National Trends in Oral Anticoagulant Use in the United States, 2007-2011

Presenter: 205730|K Kirley

September 11, 2012

News Daily News

Meta-analysis Takes an Indirect Look at Differences Among Novel Anticoagulants

September 11, 2012

News Daily News

Un Meta Análisis Estudia Indirectamente a las Diferencias Existentes entre Nuevos Anticoagulantes

September 11, 2012

Presentation

Systemic Review and Adjusted Indirect Comparison Meta-analysis of Oral Anticoagulants in A-fib

Presenter: 89964|William Baker

September 10, 2012

News Conference News ESC 2012

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Caitlin E. Cox

September 04, 2012

News Industry News

Landmark IMPROVE HF Trial Shows Evidence-Based Programs Result in Improvements in Heart Failure Patients Regardless of Race, and Improves Survival

August 30, 2012

News Conference News ESC 2012

Study Looks at Global Mortality, Stroke Rates in A-fib Patients After ER Visit

Yael L. Maxwell

August 29, 2012

Presentation ESC 2012

WOEST: First randomised trial that compares two different regimens with and without aspirin in patients on oral anticoagulant therapy (OAC) undergoing coronary stent placement (PCI)

Presenter: Willem Dewilde

August 28, 2012

News Conference News ESC 2012

WOEST: Clopidogrel Alone Works Best for PCI Patients on Oral Anticoagulants

Yael L. Maxwell

August 28, 2012

News Conference News ESC 2012

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

Caitlin E. Cox

August 27, 2012

News Industry News

Boston Scientific WATCHMAN® Left Atrial Appendage Closure Device Receives CE Mark Approval For Expanded Use

August 26, 2012

News Conference News ESC 2012

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Caitlin E. Cox

August 26, 2012

News Daily News

Tras la transfusión TAVR Atado a una Mayor Mortalidad

August 16, 2012

News Daily News

Post-TAVR Transfusion Tied to Increased Mortality

August 16, 2012

Advertisement

Watchman Device for LAA Closure Provides Net Clinical Benefit vs. Warfarin in A-fib Patients

El Dispositivo Watchman para el Cierre del AAI Ofrece Beneficios Clínicos Netos comparado con la Warfarina en Pacientes con FA

Optimal Anticoagulant/Antiplatelet Therapy in Challenging Subsets: A Post-ESC Late Breaking Trial Roundup

Anticoagulants: What is New in VTE

El Uso del Dabigatran va a Más tanto contra la FA como Fuera de Indicación

Dabigatran Usage up, Both for A-fib and Off-Label Indications

National Trends in Oral Anticoagulant Use in the United States, 2007-2011

Meta-analysis Takes an Indirect Look at Differences Among Novel Anticoagulants

Un Meta Análisis Estudia Indirectamente a las Diferencias Existentes entre Nuevos Anticoagulantes

Systemic Review and Adjusted Indirect Comparison Meta-analysis of Oral Anticoagulants in A-fib

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Landmark IMPROVE HF Trial Shows Evidence-Based Programs Result in Improvements in Heart Failure Patients Regardless of Race, and Improves Survival

Study Looks at Global Mortality, Stroke Rates in A-fib Patients After ER Visit

WOEST: First randomised trial that compares two different regimens with and without aspirin in patients on oral anticoagulant therapy (OAC) undergoing coronary stent placement (PCI)

WOEST: Clopidogrel Alone Works Best for PCI Patients on Oral Anticoagulants

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

Boston Scientific WATCHMAN® Left Atrial Appendage Closure Device Receives CE Mark Approval For Expanded Use

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Tras la transfusión TAVR Atado a una Mayor Mortalidad

Post-TAVR Transfusion Tied to Increased Mortality

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content